MPS patients help design exercise program to boost mental health
NCT ID NCT07449143
First seen Jun 24, 2026 · Last updated Aug 20, 2026 · Updated 3 times
Summary
This study aims to create a physical activity and sedentary behaviour program tailored for adults with mucopolysaccharidosis (MPS). Researchers will gather input from patients, doctors, nurses, and family members through interviews, focus groups, and workshops. The goal is to design an intervention that could improve mental health and quality of life, but the study itself does not test the program—it only develops the blueprint.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to a tailored physical activity program that improves mental health and quality of life for adults with MPS.
- What could go wrong
- This is an early, small qualitative study (50 participants) that only designs the intervention—it does not test it. The actual benefits remain uncertain.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 50 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Mar 2026
- Expected to finish
-
Sep 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Adults with Mucopolysaccharidosis, lay specialist stakeholders and specialist stakeholders who meet the eligibility criteria.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Adults with Mucopolysaccharidosis will be eligible to participate in the study if they meet the following inclusion criteria: * Diagnosed with any type of Mucopolysaccharidosis. * Aged ≥ 18 years old. * Lives in the United Kingdom. * Deemed safe to participate by a clinician (for participatory workshops). Exclusion criteria for all participants will be as follows: * Incapacity to provide informed consent. * A level of intellectual disability that would prevent the individual from making a meaningful contribution to the focus groups or workshops. * Unable to communicate in English to a sufficient level to permit engagement in the study. The circumstances in which an individual may be deemed ineligible to take part in the participatory workshops based on the clinician's assessment are as follows: * Severe joint pain. * Neurological compromise. * Stage 4 heart failure or other condition resulting in breathlessness to a level they cannot participate. * Other clinical condition which dominates the clinical picture to the extent that it dominates the symptoms and influences the findings (e.g. stroke). Specialist stakeholders will be members of staff at NHS specialist centres for Mucopolysaccharidosis who are directly involved in healthcare provision to the target population. Lay specialist stakeholders will be individuals who have been involved in supporting adults with Mucopolysaccharidosis, such as family, friends, and members of staff and volunteers at the Society for Mucopolysaccharide Diseases.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Mucopolysaccharidosis (MPS) are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Brunel University London
RECRUITINGLondon, UB8 3PH, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.